These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 9733516

  • 1. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
    Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS.
    Science; 1998 Sep 11; 281(5383):1680-3. PubMed ID: 9733516
    [Abstract] [Full Text] [Related]

  • 2. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
    Varfolomeev E, Wayson SM, Dixit VM, Fairbrother WJ, Vucic D.
    J Biol Chem; 2006 Sep 29; 281(39):29022-9. PubMed ID: 16891304
    [Abstract] [Full Text] [Related]

  • 3. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E, Goncharov T, Maecker H, Zobel K, Kömüves LG, Deshayes K, Vucic D.
    Sci Signal; 2012 Mar 20; 5(216):ra22. PubMed ID: 22434933
    [Abstract] [Full Text] [Related]

  • 4. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
    Li X, Yang Y, Ashwell JD.
    Nature; 2002 Mar 21; 416(6878):345-7. PubMed ID: 11907583
    [Abstract] [Full Text] [Related]

  • 5. TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice.
    Zhang L, Blackwell K, Workman LM, Gibson-Corley KN, Olivier AK, Bishop GA, Habelhah H.
    J Cell Sci; 2016 Apr 01; 129(7):1455-67. PubMed ID: 26872784
    [Abstract] [Full Text] [Related]

  • 6. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB, Samuel T, Reed JC.
    Oncogene; 2009 Apr 02; 28(13):1584-93. PubMed ID: 19234489
    [Abstract] [Full Text] [Related]

  • 7. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.
    Wang CY, Guttridge DC, Mayo MW, Baldwin AS.
    Mol Cell Biol; 1999 Sep 02; 19(9):5923-9. PubMed ID: 10454539
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.
    Shu HB, Takeuchi M, Goeddel DV.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13973-8. PubMed ID: 8943045
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury.
    Kim GM, Xu J, Xu J, Song SK, Yan P, Ku G, Xu XM, Hsu CY.
    J Neurosci; 2001 Sep 01; 21(17):6617-25. PubMed ID: 11517251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.
    Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T, Ashwell JD.
    Mol Cell Biol; 2005 Apr 01; 25(8):3348-56. PubMed ID: 15798218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.
    Qi H, Ohh M.
    Cancer Res; 2003 Nov 01; 63(21):7076-80. PubMed ID: 14612498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
    Conti A, Ageunnouz M, La Torre D, Cardali S, Angileri FF, Buemi C, Tomasello C, Iacopino DG, D'Avella D, Vita G, Tomasello F.
    J Neurosurg; 2005 Nov 01; 103(5):873-81. PubMed ID: 16304992
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
    Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M.
    J Invest Dermatol; 2008 May 01; 128(5):1134-47. PubMed ID: 17989734
    [Abstract] [Full Text] [Related]

  • 20. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W, Haegeman G, Beyaert R.
    J Cell Biol; 1999 Jun 28; 145(7):1471-82. PubMed ID: 10385526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.